| Business Name: |
Gist Christopher MD |
| Contact Person: |
Christopher Gist, |
| Address: |
279 Troy Road # 5, Rensselaer, New York 12144 |
| Phone Number: |
(518) 880-6300 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Fletcher Frederick J MD - Rensselaer, NY 12144
Quade Ralph MD - Rensselaer, NY 12144
Zisman Lawrence S MD - Rensselaer, NY 12144
Cohen Michael D MD - Rensselaer, NY 12144
Bidot Ramon MD - Rensselaer, NY 12144
Fisher William X MD - Rensselaer, NY 12144
Katz Michael S MD - Rensselaer, NY 12144
Barbarotto Paul D MD - Rensselaer, NY 12144
Zitwer Seth D MD - Rensselaer, NY 12144
Dyer-Martin Mary MD - Rensselaer, NY 12144
Kim Jai MD - Rensselaer, NY 12144
Gabor Michael P MD - Rensselaer, NY 12144
Abraham J David MD - Rensselaer, NY 12144
DE Camp Christopher MD - Rensselaer, NY 12144
Khuri Suheil M MD - Rensselaer, NY 12144
Alfandre James D MD - Rensselaer, NY 12144
Park Kyong M MD - Rensselaer, NY 12144
Capital Region Osteopathic Center - Rensselaer, NY 12144
Basso Deborah MD - Rensselaer, NY 12144
Corcoran Vincent MD - Rensselaer, NY 12144
|
The company Gist Christopher MD provides B2C services in the form of Doctors from its single location in New York.
1 to 4 employees work for Gist Christopher MD, and the business now earns $500.000 to $999.999 per annum.
Gist Christopher MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Gist Christopher MD, please call Christopher Gist, with the phone number (518) 880-6300 or visit its single location at 279 Troy Road # 5 in Rensselaer, New York 12144.
The location of the single location can also be found using the coordinates 42.640662,-73.699529.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.